News


All series


All News

FDA

The FDA has issued an emergency use authorization for a second vaccine, the mRNA-1273 Moderna COVID-19 Vaccine, for the prevention of coronavirus disease 2019 (COVID-19) in individuals 18 years of age and older.

Patients with HER2-positive metastatic breast cancer and brain metastases treated with the combination of tucatinib, trastuzumab, and capecitabine had significantly lengthened the time to deterioration of health-related quality of life, according to the results of an analysis of the HER2CLIMB clinical trial presented during the 2020 San Antonio Breast Cancer Symposium.